144 related articles for article (PubMed ID: 7601400)
1. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.
Cirera I; Feu F; Luca A; García-Pagán JC; Fernández M; Escorsell A; Bosch J; Rodés J
Hepatology; 1995 Jul; 22(1):106-11. PubMed ID: 7601400
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in nonresponders to the usual somatostatin dose.
Villanueva C; Planella M; Aracil C; López-Balaguer JM; González B; Miñana J; Balanzó J
Am J Gastroenterol; 2005 Mar; 100(3):624-30. PubMed ID: 15743361
[TBL] [Abstract][Full Text] [Related]
3. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects.
Sonnenberg GE; Keller U; Perruchoud A; Burckhardt D; Gyr K
Gastroenterology; 1981 Mar; 80(3):526-32. PubMed ID: 6108898
[TBL] [Abstract][Full Text] [Related]
4. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
Bosch J; Kravetz D; Rodes J
Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
[TBL] [Abstract][Full Text] [Related]
5. [Effect of somatostatin on splanchnic hemodynamics in liver cirrhosis].
Merkel C; Gatta A; Zuin R; Finucci GF; Arnaboldi L; Ruol A
Minerva Med; 1984 Nov; 75(44):2673-8. PubMed ID: 6151151
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of octreotide in patients with hepatic cirrhosis.
McCormick PA; Chin J; Greenslade L; Karatapanis S; Dick R; McIntyre N; Burroughs AK
Hepatology; 1995 May; 21(5):1255-60. PubMed ID: 7737631
[TBL] [Abstract][Full Text] [Related]
7. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
Baik SK; Jeong PH; Ji SW; Yoo BS; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Chang SJ; Lee SS
Am J Gastroenterol; 2005 Mar; 100(3):631-5. PubMed ID: 15743362
[TBL] [Abstract][Full Text] [Related]
8. [Dosage dependence of the effect of somatostatin on human splanchnic blood flow].
Keller U; Sonnenberg GE; Kayasseh L; Gyr K; Perruchoud A
Schweiz Med Wochenschr; 1979 Apr; 109(16):595-6. PubMed ID: 432587
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
Lee WC; Lin HC; Yang YY; Hou MC; Lee FY; Chang FY; Lee SD
Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172
[TBL] [Abstract][Full Text] [Related]
10. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis.
Feu F; Bordas JM; Luca A; García-Pagán JC; Escorsell A; Bosch J; Rodés J
Hepatology; 1993 Nov; 18(5):1082-9. PubMed ID: 8225212
[TBL] [Abstract][Full Text] [Related]
11. Effect of bolus injection and continuous infusion of somatostatin on gastric perfusion in cirrhotic patients with portal-hypertensive gastropathy.
Panés J; Piqué JM; Bordas JM; Casadevall M; Terés J; Bosch J; Rodés J
Hepatology; 1994 Aug; 20(2):336-41. PubMed ID: 7913906
[TBL] [Abstract][Full Text] [Related]
12. Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis.
Merkel C; Gatta A; Caregaro L; Sacerdoti D; Rondana M; Ruol A
Scand J Clin Lab Invest; 1987 Nov; 47(7):667-72. PubMed ID: 2891182
[TBL] [Abstract][Full Text] [Related]
13. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis.
Bandi JC; García-Pagán JC; Escorsell A; François E; Moitinho E; Rodés J; Bosch J
Hepatology; 1998 Sep; 28(3):677-82. PubMed ID: 9731558
[TBL] [Abstract][Full Text] [Related]
14. Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension.
Hernández-Guerra M; García-Pagán JC; Turnes J; Bellot P; Deulofeu R; Abraldes JG; Bosch J
Hepatology; 2006 Mar; 43(3):485-91. PubMed ID: 16496307
[TBL] [Abstract][Full Text] [Related]
15. Effects of octreotide on central hemodynamics and systemic oxygen use in patients with viral cirrhosis.
Lin HC; Hou MC; Lee WC; Huang YT; Lee FY; Chang FY; Tsai YT; Lee SD
Am J Gastroenterol; 1999 Apr; 94(4):1012-7. PubMed ID: 10201475
[TBL] [Abstract][Full Text] [Related]
16. Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis.
Bacq Y; Gaudin C; Hadengue A; Roulot D; Braillon A; Moreau R; Lebrec D
Hepatology; 1991 Sep; 14(3):483-7. PubMed ID: 1874493
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of nipradilol and the acute and chronic splanchnic hemodynamic effects of a new beta-blocker with nitrovasodilating properties in patients with liver cirrhosis.
Sugano S; Kawafune T; Suzuki T; Kubota M; Okajima T; Sumino Y; Akita H
Am J Gastroenterol; 1995 May; 90(5):788-93. PubMed ID: 7733089
[TBL] [Abstract][Full Text] [Related]
18. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension.
Escorsell A; Bandi JC; Andreu V; Moitinho E; García-Pagán JC; Bosch J; Rodés J
Gastroenterology; 2001 Jan; 120(1):161-9. PubMed ID: 11208725
[TBL] [Abstract][Full Text] [Related]
19. Immediate effects of different schedules of somatostatin on portal pressure in patients with liver cirrhosis.
Zhang C; Xu JM; Kong DR; Min XK; Chen R
J Clin Pharm Ther; 2013 Jun; 38(3):206-11. PubMed ID: 23437909
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis.
Luca A; García-Pagán JC; Bosch J; Feu F; Jiménez W; Ginés A; Fernández M; Escorsell A; Arroyo V; Rodés J
Hepatology; 1995 Sep; 22(3):753-8. PubMed ID: 7657279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
